David Roman
Stock Analyst at Goldman Sachs
(2.27)
# 2,712
Out of 4,983 analysts
46
Total ratings
50%
Success rate
-1.33%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SI Shoulder Innovations | Initiates: Buy | $20 | $15.70 | +27.39% | 1 | Aug 25, 2025 | |
| CARL Carlsmed | Initiates: Buy | $19 | $15.30 | +24.18% | 1 | Aug 18, 2025 | |
| OMDA Omada Health | Initiates: Buy | $29 | $23.68 | +22.47% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $91.54 | +13.61% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $23.29 | -31.30% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $332.13 | +14.41% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $72.08 | -30.63% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $99.12 | +4.92% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $7.87 | +27.06% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $77.48 | +5.83% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $23.20 | -0.86% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $132.76 | +16.00% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $12.43 | +93.08% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $74.13 | -4.22% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $54.93 | +0.13% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $23.87 | +75.95% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $174.40 | -28.90% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $376.62 | +13.38% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $75.09 | +19.86% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $98.98 | -9.07% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $434.50 | +15.07% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $186.21 | +47.15% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $94.19 | -11.88% | 1 | May 30, 2024 |
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $15.70
Upside: +27.39%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $15.30
Upside: +24.18%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $23.68
Upside: +22.47%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $91.54
Upside: +13.61%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $23.29
Upside: -31.30%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $332.13
Upside: +14.41%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $72.08
Upside: -30.63%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $99.12
Upside: +4.92%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.87
Upside: +27.06%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $77.48
Upside: +5.83%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $23.20
Upside: -0.86%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $132.76
Upside: +16.00%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $12.43
Upside: +93.08%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $74.13
Upside: -4.22%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $54.93
Upside: +0.13%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $23.87
Upside: +75.95%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $174.40
Upside: -28.90%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $376.62
Upside: +13.38%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $75.09
Upside: +19.86%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $98.98
Upside: -9.07%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $434.50
Upside: +15.07%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $186.21
Upside: +47.15%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $94.19
Upside: -11.88%